Androgens in post-menopausal patients with systemic sclerosis

Rheumatology (Oxford). 2015 Apr;54(4):744-6. doi: 10.1093/rheumatology/keu432. Epub 2014 Dec 17.

Authors

Dijana Perković¹, Dušanka Martinović Kaliterna², Zrinka Jurišić², Miloš Lalovac², Mislav Radić²

Affiliations

¹ Division of Rheumatology and Clinical Immunology, Division of Cardiology, University Hospital Center Split, Split and Department of Gastroenterology, General Hospital Dubrovnik, Dubrovnik, Croatia. dijana.perkovic@hotmail.com.
² Division of Rheumatology and Clinical Immunology, Division of Cardiology, University Hospital Center Split, Split and Department of Gastroenterology, General Hospital Dubrovnik, Dubrovnik, Croatia.

PMID: 25524921
DOI: 10.1093/rheumatology/keu432

No abstract available

Publication types

Letter

MeSH terms

Aged
Androstenedione / blood*
Antibodies, Antinuclear / immunology
Case-Control Studies
DNA Topoisomerases, Type I
Dehydroepiandrosterone Sulfate / blood*
Estradiol / blood*
Female
Humans
Middle Aged
Nuclear Proteins / immunology
Postmenopause / blood*
Postmenopause / immunology
Scleroderma, Diffuse / blood
Scleroderma, Diffuse / immunology
Scleroderma, Localized / blood
Scleroderma, Localized / immunology
Scleroderma, Systemic / blood*
Scleroderma, Systemic / immunology
Testosterone / blood*

Substances

Antibodies, Antinuclear
Nuclear Proteins
Scl 70 antigen, human
anticentromere antibody
Testosterone
Androstenedione
Estradiol
Dehydroepiandrosterone Sulfate
DNA Topoisomerases, Type I